(This Nov. 23rd story corrects fiscal year of expected regulatory approval in the 10th paragraph to March-end 2021, not March-end 2020) By Rocky Swift (Reuters) – Japan’s biggest drugmaker, Takeda Pharmaceutical Co Ltd, said long-term data show better outcomes... More »
CHICAGO (Reuters) – An additional six months of data from a late-stage trial of Takeda Pharmaceutical Co’s experimental dengue vaccine again showed it failed to protect against one of the four types of the virus in an important patient group, researchers said ... More »
TOKYO (Reuters) – Takeda Pharmaceutical Co Ltd on Tuesday said it has received U.S. approval for its $62 billion acquisition of London-listed Shire Plc, taking the Japanese firm one step closer to its goal of becoming a global top 10 drugmaker. Takeda in a pre... More »
Samsung Bioepis Co Ltd said on Monday it will fund and develop multiple original drugs in partnership with Japan's Takeda Pharmaceutical Co Ltd, expanding its business scope beyond copies of existing biologic drugs. More »
Logos of Japanese Takeda Pharmaceutical Co are seen at an office building in Glattbrugg near Zurich March 7, 2012. REUTERS/Arnd Wiegmann/File Photo – RTX2RH16 Japan’s Takeda Pharmaceutical Co (4502.T) flagged its appetite for fresh acquisitions to bolster its ... More »
